Naproxen sodium/metoclopramide: metoclopramide/naproxen-sodium, MT 100, naproxen-sodium/metoclopramide.
D000818:Animals; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000188:drug therapy*
D004338:Drug Combinations; C476639:MT 100; D009288:Naproxen; D008787:Metoclopramide